Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Change in Intangibles (2016 - 2025)

Cytosorbents (CTSO) has disclosed Change in Intangibles for 14 consecutive years, with -$72000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Intangibles fell 148.98% year-over-year to -$72000.0, compared with a TTM value of $123087.0 through Sep 2025, down 66.77%, and an annual FY2024 reading of $385087.0, down 3.27% over the prior year.
  • Change in Intangibles was -$72000.0 for Q3 2025 at Cytosorbents, down from $94879.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $196061.0 in Q2 2021 and bottomed at -$72000.0 in Q3 2025.
  • Average Change in Intangibles over 5 years is $97864.8, with a median of $101173.0 recorded in 2024.
  • The sharpest move saw Change in Intangibles surged 649.48% in 2023, then tumbled 148.98% in 2025.
  • Year by year, Change in Intangibles stood at $140322.0 in 2021, then tumbled by 105.24% to -$7357.0 in 2022, then soared by 649.48% to $40425.0 in 2023, then skyrocketed by 36.27% to $55087.0 in 2024, then plummeted by 230.7% to -$72000.0 in 2025.
  • Business Quant data shows Change in Intangibles for CTSO at -$72000.0 in Q3 2025, $94879.0 in Q2 2025, and $45121.0 in Q1 2025.